SEC Form 3 · accession 0001140361-26-029804
Freenome, Inc. · FRNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Riley Charles Ennis
Officer — Chief Product Officer
Period of report
Jul 20, 2026
Accepted (ET)
Jul 27, 2026 · 8:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002017526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,490,453 | D | ||
| Common StockF1 | holding | — | — | — | 373,913 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.85 | holding | — | — | — | — | Jun 21, 2030 | Common Stock | 310,958 | — | D |
| Stock Option (right to buy)F6,F2 | $15.91 | holding | — | — | — | — | Jun 21, 2032 | Common Stock | 281,369 | — | D |
| Stock Option (right to buy)F6,F3 | $11.88 | holding | — | — | — | — | Feb 17, 2033 | Common Stock | 75,082 | — | D |
| Stock Option (right to buy)F6,F4 | $18.24 | holding | — | — | — | — | Feb 15, 2034 | Common Stock | 118,471 | — | D |
| Stock Option (right to buy)F6,F5 | $14.00 | holding | — | — | — | — | Mar 10, 2035 | Common Stock | 221,457 | — | D |
Explanation of responses
- F1Represents shares held by the Riley Ennis Irrevocable Trust dated 1/14/21. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F2The shares subject to this option are fully vested.
- F325% of the shares subject to this option shall vest and become exercisable on February 2, 2024 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F4The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from February 16, 2024, subject to the Reporting Person's continued service on each such vesting date.
- F525% of the shares subject to this option shall vest and become exercisable on February 15, 2026 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F6This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events.
Remarks
Exhibit 24 - Power of Attorney